VON WILLEBRAND FACTOR ANTIGEN IN BLOOD PLASMA OF PATIENTS WITH URINARY BLADDER CARCINOMA

By Zietek Z.   Iwan-Zietek I.   Paczulski R.   Kotschy M.   Wolski Z.  

Thrombosis Research, Vol. 83, Iss. 5, 1996-09 ,pp. : 399-402

Elsevier

Access to resources Recommend Favorite

Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients

By Koo B.-H.   Oh D.   Chung S.Y.   Kim N.K.   Park S.   Jang Y.   Chung K.-H.  

Thrombosis Research, Vol. 105, Iss. 6, 2002-03 ,pp. : 471-476

Elsevier

Access to resources Recommend Favorite

Von Willebrand Factor in Plasma of Patients with Advanced Stages of Larynx Cancer - Evidence for presence of specific binding sites and modification of von Willebrand factor structure and function

By Paczuski R.   Bialkowska A.   Kotschy M.   Burduk D.   Betlejewski S.  

Thrombosis Research, Vol. 95, Iss. 4, 1999-08 ,pp. : 197-200

Elsevier

Access to resources Recommend Favorite

Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris

By Gravning Jørgen   Ueland Thor   Mørkrid Lars   Endresen Knut   Aaberge Lars   Kjekshus John  

Scandinavian Cardiovascular Journal, Vol. 42, Iss. 3, 2008-01 ,pp. : 214-221

Informa Healthcare

Access to resources Recommend Favorite

Plasma Tissue Factor Pathway Inhibitor and Tissue Factor Antigen Levels After Administration of Heparin in Patients With Angina Pectoris - Relationship between free and endothelial cell-associated forms of TFPI

By Soejima H.   Ogawa H.   Yasue H.   Nishiyama K.   Kaikita K.   Misumi K.   Takazoe K.   Kugiyama K.   Tsuji I.   Kumeda K.   Nakamura S.  

Thrombosis Research, Vol. 93, Iss. 1, 1999-01 ,pp. : 17-25

Elsevier

Access to resources Recommend Favorite